ResMed (RMD) EV/EBITDA US GAAP (year values) |
|||||||||
2022 | 2023 | 2023 | 2024 | 2024 | LTM ? | CAGR 5 years ? | |||
EV/EBITDA | ? | 26.6 | 1.01 | 24.6 | 17.0 | 18.0 | 12.8 | ||
Changes by years, y/y, % | -96% | +2 337% | -31% | +6% | -4.0% |
ResMed. EV/EBITDA
ResMed. EV/EBITDA, changes, %
ResMed (RMD) EV/EBITDA US GAAP (quarter values) |
||||||||
2024Q3 | 2024Q3 | 2024Q4 | 2024Q4 | 2025Q1 | LTM ? | |||
EV/EBITDA | ? | 0.64 | 20.0 | 17.6 | 18.1 | 21.5 | 12.8 | |
Changes by years, y/y, % | -98% | -22% | -29% | -27% | +28% | |||
Changes by quarters, q/q, % | -97% | +3 036% | -12% | +3% | +19% |